Canaccord analyst Susan Anderson raised the firm’s price target on Beauty Health to $4 from $3 and keeps a Hold rating on the shares. The firm said its Q4 results were driven by continued strong consumables demand in the Americas but offset by weaker device sales but raised its target due to better-than-expected adj. EBITDA guidance given.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SKIN:
- Beauty Health Company’s Restructuring Risks: Balancing Cost-Cutting with the Perils of Lost Knowledge and Morale
- Beauty Health price target raised to $3 from $2 at Piper Sandler
- Beauty Health Enhances Transparency with Financial Report Integration
- Beauty Health sees FY24 revenue flat to up low single digits
- Beauty Health sees Q1 revenue $77M-$83M, consensus $85.5M
